GMThe responsibility for the failed developement of AOD falls...

GM
The responsibility for the failed developement of AOD falls largely at the
feet of the original board.

At the time the company put out a paper hypothesising that oral availability was to blame for not achieving statistical significance.
There has been rodent studies confirmimg oral availability.
JV has previously made a strong case the clinical trials were bungled.
GRAS is the money option after a failed trial with no takers for funding further developement. Have a look at the unscientifically tested rubbish on the chemists shelves.
It may be academia is very wary of supporting a failed drug , even a GRAS, which should be beyond doubt after all the trial subjects.
The BB industry is doing a lot of valuable clinical trials!
They even have an improved diet regime with dose first in morning then fast and a second dose in the evening.

I have read oral needs four times the dosage of injectable.
As JV has stated a legal , mass produced cost of goods should blow the pirates out of the water.
I feel your pain GM at the time i lost a house deposit.
Biotech is high risk, remember the caveat forward looking statements etc
At least biotech is altruistic , saving lives etc.
Its not like cannabals with forks like the carbon lobby poisoning the earth for future generations.